GODAVARIB Godavari Biorefineries Q3 FY25 results (Oct–Dec 2024) and concall
Godavari Biorefineries reported a 12% YoY revenue growth to Rs. 447 crores in Q3 FY25, with an EBITDA of Rs. 40 crores and PAT of Rs. 6 crores. The company made significant strides in strategic diversification, including debottlenecking bio-based chemical capacity and securing a license for biobutanol production. Despite these positives, the nine-month financials showed negative EBITDA and PAT, impacted by headwinds in the sugar segment like reduced quotas and delayed crushing.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q2 FY25 | Q3 FY25 |
|---|---|---|
| Revenue | 321 | 447 |
| EBITDA | -33 | 36 |
| Net profit | -75 | 6 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
